C.Q. Pharmaceutical Holding Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Wei Liu
Chief executive officer
CN¥1.2m
Total compensation
CEO salary percentage | n/a |
CEO tenure | 1.7yrs |
CEO ownership | n/a |
Management average tenure | 1.8yrs |
Board average tenure | 1.7yrs |
Recent management updates
Recent updates
Is C.Q. Pharmaceutical Holding (SZSE:000950) A Risky Investment?
Dec 03C.Q. Pharmaceutical Holding's (SZSE:000950) Returns On Capital Not Reflecting Well On The Business
Nov 12C.Q. Pharmaceutical Holding Co., Ltd. (SZSE:000950) Doing What It Can To Lift Shares
Oct 25Is C.Q. Pharmaceutical Holding (SZSE:000950) Using Too Much Debt?
Jul 13C.Q. Pharmaceutical Holding Co., Ltd. (SZSE:000950) Doing What It Can To Lift Shares
Jun 11Does C.Q. Pharmaceutical Holding (SZSE:000950) Have A Healthy Balance Sheet?
Mar 28CEO
Wei Liu (49 yo)
1.7yrs
Tenure
CN¥1,233,200
Compensation
Mr. Wei Liu is General Manager of C.Q. Pharmaceutical Holding Co., Ltd. since April 25, 2023.He is Director of C.Q. Pharmaceutical Holding Co., Ltd. from May 18, 2023. He is President of Chongqing Pharmac...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
GM & Director | 1.7yrs | CN¥1.23m | no data | |
Financial Director | 2.8yrs | CN¥1.08m | 0.0012% CN¥ 140.1k | |
Executive Deputy GM & Director | 7.3yrs | CN¥1.42m | no data | |
Deputy GM & Non-Independent Director | 1.8yrs | CN¥1.17m | no data | |
Accounting Supervisor | no data | no data | no data | |
Deputy General Manager | 1.8yrs | no data | no data |
1.8yrs
Average Tenure
52yo
Average Age
Experienced Management: 000950's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
GM & Director | 1.6yrs | CN¥1.23m | no data | |
Executive Deputy GM & Director | 6yrs | CN¥1.42m | no data | |
Deputy GM & Non-Independent Director | 1.1yrs | CN¥1.17m | no data | |
Chairman | 7.3yrs | CN¥1.45m | 0.023% CN¥ 2.7m | |
Director | 1.8yrs | no data | no data | |
Non Independent Director | 3.1yrs | no data | no data | |
Non Independent Director | 3.1yrs | no data | no data | |
Non Employee Supervisor | 3.1yrs | no data | no data | |
Independent Director | 1.1yrs | no data | no data | |
Independent Director | 1.1yrs | no data | no data | |
Independent Director | 1.1yrs | no data | no data | |
Independent Director | 1.1yrs | no data | no data |
1.7yrs
Average Tenure
50yo
Average Age
Experienced Board: 000950's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 10:08 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
C.Q. Pharmaceutical Holding Co., Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Feifei Xu | China Merchants Securities Co. Ltd. |
Tielin Chen | Topsperity Securities |
Xinming Zhou | Topsperity Securities |